Eli Lilly Profit Margin 2006-2019 | LLY

Current and historical gross margin, operating margin and net profit margin for Eli Lilly (LLY) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Eli Lilly net profit margin as of June 30, 2019 is 33.76%.
Eli Lilly Annual Profit Margins
Eli Lilly Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $104.170B $24.556B
Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. They were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and they remain true to that mission in all their work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $344.992B 15.02
Roche Holding AG (RHHBY) Switzerland $246.683B 0.00
Merck (MRK) United States $216.838B 17.83
Pfizer (PFE) United States $200.777B 11.82
Novartis AG (NVS) Switzerland $196.934B 16.95
Novo Nordisk (NVO) Denmark $123.207B 21.77
AstraZeneca (AZN) United Kingdom $115.026B 22.25
Sanofi (SNY) France $112.411B 13.81
AbbVie (ABBV) United States $109.053B 8.74
GlaxoSmithKline (GSK) United Kingdom $105.181B 13.22
Bristol-Myers Squibb (BMY) United States $84.340B 11.96
Bayer (BAYRY) Germany $67.293B 9.80
H Lundbeck (HLUYY) Denmark $6.598B 9.52